Senior Sales Consultant – Hematology (Quebec) at Eli Lilly and Company

Quebec, Quebec, Canada

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Experience in hematology
Motivated and entrepreneurial mindset
Strong relationships with key oncology centers and opinion leaders, particularly in Quebec
In-depth knowledge of the healthcare system, regional and national cancer care initiatives, drug access, and therapeutic options
Ability to establish and deepen relationships with key clients such as hematologists, hemato-oncologists, drug access navigators, nurse educators, and pharmacists
Proficiency in interpreting data to develop and implement detailed territory plans and address specific challenges

Responsibilities

Deliver superior customer experience by identifying essential needs and providing solutions at the center/account and national levels
Shape the environment to facilitate access to and use of Lilly's hematology product, while collaborating with other Hematology team members
Serve as a point of contact for Lilly's cross-functional teams, including the LillyPlus Patient Support Program (PSP), medical affairs, patient access, and marketing
Help clinicians and multidisciplinary teams promote access and appropriate use of Lilly's hematology product using a value-based interaction framework
Provide relevant and up-to-date product information and services
Build a strong reputation for Lilly in hematology
Support the cross-functional team in planning and engaging opinion leaders for commercial initiatives
Establish trust-based relationships with opinion leaders and key stakeholders through digital and in-person means
Conduct assessments of key centers and the market to develop business plans supporting the hematology strategy
Gather information and leverage sales performance data

Skills

Pharmaceutical Sales

Hematology

Oncology

KOL Management

Sales Consulting

Customer Relationship Management

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free